IFN-γ–related mRNA profile predicts clinical response to PD-1 blockadeMark Ayers, Terrill K. McClanahan, Tanguy Y. Seiwert et al.|Journal of Clinical Investigation|2017Cited by 3.9k
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapyRăzvan Cristescu, David R. Kaufman, Robin Mogg et al.|Science|2018Cited by 2.3k
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinomaRobert I. Haddad, Ranee Mehra, Tanguy Y. Seiwert et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 96
The Effect of Human Herpesvirus-6 (HHV-6) on Cultured Human Neural Cells: Oligodendrocytes and MicrogliaAndrew Albright, Francisco González‐Scarano, Ehud Lavi et al.|Journal of NeuroVirology|1998Cited by 89
Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).Robert I. Haddad, Ranee Mehra, Tanguy Y. Seiwert et al.|Journal of Clinical Oncology|2017Cited by 56